PEAK6 Investments’s Repligen RGEN Stock Holding History

PEAK6 Investments’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,000	Closed	-$477K	–	4739
2023 Q3	$477K	Buy	+3,000	New	+$490K	﹤0.01%	2427
2023 Q2	–	Sell	-2,000	Closed	-$337K	–	4576
2023 Q1	$337K	Hold	2,000	–	–	﹤0.01%	2722
2022 Q4	$339K	Buy	+2,000	New	+$363K	﹤0.01%	2852
2022 Q2	–	Sell	-23,200	Closed	-$4.36M	–	6464
2022 Q1	$4.36M	Buy	+23,200	New	+$4.41M	0.01%	1205
2021 Q4	–	Sell	-25,900	Closed	-$7.49M	–	5684
2021 Q3	$7.49M	Sell	25,900 -3,000	-10%	-$770K	0.02%	880
2021 Q2	$5.77M	Sell	28,900 -17,900	-38%	-$3.47M	0.01%	1012
2021 Q1	$9.1M	Buy	+46,800	New	+$9.6M	0.02%	688
2020 Q4	–	Sell	-3,200	Closed	-$472K	–	5053
2020 Q3	$472K	Buy	+3,200	New	+$457K	﹤0.01%	2902
2020 Q2	–	Sell	-8,200	Closed	-$792K	–	4752
2020 Q1	$792K	Buy	+8,200	New	+$792K	﹤0.01%	1687
2018 Q4	–	Sell	-15,400	Closed	-$854K	–	4565
2018 Q3	$854K	Buy	+15,400	New	+$794K	﹤0.01%	2123

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PEAK6 Investments's RGEN Position: Q2 2023 in Review

PEAK6 Investments sold out of Repligen (RGEN) in Q2 2023, closing a stake of 291 shares — an estimated $49K sold.

PEAK6 Investments first reported a position in RGEN in Q1 2020 and held it in 9 quarters. The position peaked at $1.22M in Q1 2021. 448 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

PEAK6 Investments reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
PEAK6 Investments sold 291 Repligen shares in Q2 2023, an estimated $49K.
PEAK6 Investments first reported a position in Repligen in Q1 2020 and held it in 9 quarters.
PEAK6 Investments's Repligen position peaked at $1.22M in Q1 2021.
448 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on PEAK6 Investments's 13F filing for Q2 2023, filed 11 Aug 2023.